Cell cycle control of B-cell mass

B 细胞团的细胞周期控制

• 批准号: 6826761
• 负责人: Gay M Crooks
• 金额: $ 22.85万
• 依托单位: CHILDREN'S HOSPITAL OF LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-07-05 至 2006-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6826761
• 关键词: NOD mouse; SCID mouse; bone marrow transplantation; cell cycle; cell differentiation; cell growth regulation; cell proliferation; cyclin dependent kinase; cyclins; enzyme inhibitors; gene expression; genetic regulation; genetically modified animals; insulin dependent diabetes mellitus; laboratory mouse; pancreatic duct; pancreatic islets; regeneration; tissue /cell culture; transfection; transfection /expression vector

DESCRIPTION (provided by applicant): Understanding the mechanisms that regulate pancreatic beta-cell development is critical to the development of novel approaches to enhance regeneration and viability of beta-cells in patients with Type1 Diabetes. Our recent studies suggest key roles for two cell cycle genes, p57kip2 and cyclin D2, in differentiation and proliferation of pancreatic beta-cells during embryonic and postnatal life. Our goal in these collaborative R01 proposals is to explore further the roles of p57 kip2 and cyclin D2 in postnatal a-cell neogenesis and proliferation using novel "gain of function" approaches. Our Specific Aims are (1) To determine if postnatal a-cell neogenesis originates from the epithelial cells of the ducts and the role of p57kip2 expression in mediating post-natal beta-cell differentiation; these studies will use the combination of a novel model in which epithelial cells of the pancreatic ducts are derived from the transplanted bone marrow of GFP transgenic mice, and lentiviral vectors to express p57kip2; (2) To determine whether constitutive expression of cyclin D2 is sufficient to induce post natal beta-cell replication; these studies will use both in vitro (viral vector mediated gene expression in islet cultures) and in vivo (inducible expression of cyclin D2 in transgenic mice) models. These collaborative R01 applications bring together three investigators from the fields of developmental biology of the pancreas (Dr. Anil Bhushan), hematopoietic stem cell biology (Dr. Gay Crooks) and gene transfer and expression using viral vectors (Dr. Donald Kohn). The combination of expertise provided by this diverse group of investigators generates a unique opportunity for innovative and synergistic research relevant to Type 1 Diabetes.

描述（由申请人提供）： 了解调节胰腺β细胞发育的机制对于开发新方法以增强1型糖尿病患者β细胞的再生和活力至关重要。我们最近的研究表明，两个细胞周期基因，p57 kip 2和cyclin D2，在胚胎和出生后的胰腺β细胞的分化和增殖的关键作用。我们的目标是在这些合作R 01的建议是进一步探讨p57 kip 2和细胞周期蛋白D2的作用，在出生后的a细胞新生和增殖，使用新的“获得功能”的方法。我们的具体目标是：（1）确定出生后a细胞新生是否起源于胰管上皮细胞以及p57 kip 2表达在介导出生后β细胞分化中的作用;这些研究将使用一种新的模型，其中胰管上皮细胞来源于GFP转基因小鼠的移植骨髓，并且慢病毒载体表达p57 kip 2;（2）为了确定细胞周期蛋白D2的组成型表达是否足以诱导纳塔尔后β细胞复制;这些研究将使用体外（胰岛培养物中病毒载体介导的基因表达）和体内（转基因小鼠中细胞周期蛋白D2的诱导型表达）模型。这些合作R 01应用程序汇集了来自胰腺发育生物学（Anil Bhushan博士），造血干细胞生物学（Gay Crooks博士）和使用病毒载体的基因转移和表达（Donald Kohn博士）领域的三名研究人员。这个多样化的研究小组提供的专业知识的结合为1型糖尿病相关的创新和协同研究提供了独特的机会。